This article was originally published in SRA
Israel issues circular on vitamin C as a part of a product brand name
You may also be interested in...
The UK life sciences trade group says the “ill-considered” guidance will result in duplicative and costly repetition and dent industry’s confidence in the government’s competence.
Sponsors of new and existing medicines in New Zealand will have to update their product labels within specified deadlines to include warning statements about certain allergens.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.